BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Fluorocytosine | 5-Fluorocytosine, a fluorinated pyrimidine analogue, is a synthetic antifungal medication. Uses: Antifungal agents; antimetabolites. Group: Pharmaceutical. Alternative Names: Flucytosine; Flucytosin; Ancobon; Ancotil; 4-Amino-5-fluoro-2(1H)-pyrimidine; 5-FC; NSC 103805; 6-Amino-5-fluoro-2(1H)-pyrimidinone. CAS No. 2022-85-7. Pack Sizes: 1mg;1g;10g. Product ID: BBF-04516. Molecular formula: C4H4FN3O. Mole weight: 129.09. Custom synthesis is available. Send your inquiries for more information. |  London |
| Fluorometholone | Fluorometholone is a corticosteroid, most often used after laser-based refractive surgery. It is marketed under the brand names FML (Allergan) and Flarex (Alcon). Fluorometholone acetate ophthalmic suspension is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. Group: Pharmaceutical. Alternative Names: FML; Flarex; Oxylone acetate; Fluorometholone 17-acetate; UNII-9I50C3I3OK; NSC47438; NSC-47438; NSC 47438. CAS No. 426-13-1. Pack Sizes: 10 g. Product ID: B2692-301378. Molecular formula: C22H29FO4. Mole weight: 376.468. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone Acetate | Fluorometholone acetate is a synthetic corticosteroid used in the treatment of steroid responsive inflammatory conditions of the eye. Group: Pharmaceutical. Alternative Names: (6α,11β)-17-(Acetyloxy)-9-fluoro-11-hydroxy-6-methylpregna-1,4-diene-3,20-dione; 6α-Methyl-9α-fluoro-17-acetoxy-21-deoxyprednisolone; Eflone; Flarex; NSC 47438; Oxylone Acetate; U 17323. CAS No. 3801-6-7. Pack Sizes: 250 mg. Product ID: B2692-393472. Molecular formula: C24H31FO5. Mole weight: 418.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluorometholone Impurity A | An impurity in the synthesis of Fluorometholone, a glucocorticoid used for the treatment of eye conditions caused by inflammation. Group: Pharmaceutical. Alternative Names: 11β,17α-Dihydroxy-6α-methylpregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione,11,17-dihydroxy-6-methyl-, (6a,11b)-; 11beta,17alpha-Dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione; NSC 125051; Methyl Prednisolone Intermediates Deltamedrane; 11,17-Dihydroxy-6-methyl-(6α,11β)-pregna-1,4-diene-3,20-dione; Fluorometholone USP Related Ccompound A; Deltamedrane. CAS No. 6870-94-6. Pack Sizes: 25 mg. Product ID: NP3143. Molecular formula: C22H30O4. Mole weight: 358.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluoronaphthalene | An impurity of Duloxetine, which is a serotonin-norepinephrine reuptake inhibitor used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. Group: Pharmaceutical. Alternative Names: Naphthalene, 1-fluoro-; 1-Fluoronaphthalene; NSC 4690; α-Fluoronaphthalene; Duloxetine USP Impurity G; Duloxetine EP Impurity G. CAS No. 321-38-0. Pack Sizes: 1mg;1g;10g. Product ID: NP2663. Molecular formula: C10H7F. Mole weight: 146.16. Custom synthesis is available. Send your inquiries for more information. | London |
| Flupentiol | Flupentiol, a thioxanthene derivative that may exist in two isomeric forms, is a typical antipsychotic drug of the thioxanthene class. Flupentixol is also used in low doses as an antidepressant. Group: Pharmaceutical. Alternative Names: 2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; Flupenthixol, Flupenthixol, Depixol, Fluanxol, Emergil, Siplaril. CAS No. 2709-56-0. Pack Sizes: 1mg;1g;10g. Product ID: 2709-56-0. Molecular formula: C23H25F3N2OS. Mole weight: 434.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluphenazine-[d8] Dihydrochloride | Fluphenazine-[d8] Dihydrochloride is the labelled analogue of Fluphenazine. Fluphenazine is an antipsychotic medication. Group: Pharmaceutical. Alternative Names: 4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazine-d8-ethanol Dihydrochloride; Fluphenazine-d8 Dihydrochloride. Pack Sizes: 10 mg. Product ID: BLP-005488. Molecular formula: C22H20D8Cl2F3N3OS. Mole weight: 518.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluphenazine Decanoate Impurity 3 | Fluphenazine Decanoate Impurity 3 is one of Fluphenazine impurities. Fluphenazine is a phenothiazine antipsychotic, a dopaminergic antagonist and an antiviral agent. Group: Pharmaceutical. Alternative Names: Fluphenazine decanoate N-1-oxide; Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester, N-1-oxide; 2-(4-Oxo-4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-4lambda 5-piperazin-1-yl)ethyl decanoate; 4-(2-(decanoyloxy)ethyl)-1-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine 1-oxide. CAS No. 76013-31-5. Pack Sizes: 5 mg. Product ID: B0963-151110. Molecular formula: C32H44F3N3O3S. Mole weight: 607.77. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluralaner | Fluralaner is a systemic insecticide and acaricide. It can be used for flea treatment in dogs. Uses: Flea treatment in dogs. Group: Pharmaceutical. Alternative Names: AH252723; AH-252723; AH 252723; A-1443; A1443; A 1443; Fluralaner, trade name: Bravecto. 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide. CAS No. 864731-61-3. Pack Sizes: 100 mg. Product ID: B0084-476691. Molecular formula: C22H17Cl2F6N3O3. Mole weight: 556.29. Custom synthesis is available. Send your inquiries for more information. | London |
| Flurbiprofen | Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) belonging to the propionic acid class. It exerts analgesic, anti-inflammatory, and antipyretic effects by reversibly inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis. Clinically, it is used to manage pain and inflammation in conditions such as rheumatoid arthritis, osteoarthritis, and postoperative discomfort. Uses: Anti-inflammatory agents, non-steroidal. Group: Pharmaceutical. Alternative Names: 2-Fluoro-α-methyl[1,1'-biphenyl]-4-acetic acid; (±)-Flurbiprofen; 2-(2-Fluoro-1,1'-biphenyl-4-yl)propanoic acid; 2-(2-Fluoro-4-biphenyl)propionic acid; 2-(2-Fluoro-4-biphenylyl)propanoic acid; 2-(2-Fluoro-4-biphenylyl)propionic acid; 2-Fluoro-α-methyl-4-biphenylacetic acid; 2-Fluoro-α-methyl-4-diphenylacetic acid; 3-Fluoro-4-phenylhydratropic acid; Adfeed; Ansaid; Antadys; BTS 18322; Cebutid; dl-2-(2-Fluoro-4-biphenylyl)propionic acid; dl-Flurbiprofen; Flugalin; Flurbifen; Fluribiprofen; Fluroben; Flurofen; FP 70; FP-A; Froben; rac-Flurbiprofen; Racemic flurbiprofen; Stayban; Synalgo; U 27182; Urbifen; Zepolas. CAS No. 5104-49-4. Pack Sizes: 1mg;1g;10g. Product ID: BBF-04023. Molecular formula: C15H13FO2. Mole weight: 244.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Flurbiprofen Sodium | Flurbiprofen Sodium is a nonsteroidal anti-inflammatory drug (NSAID) derived from propionic acid. It functions as a potent inhibitor of cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins, which are mediators of pain, inflammation, and fever. Group: Pharmaceutical. Alternative Names: [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, sodium salt (1:1); 2-(2-Fluorobiphenyl-4-yl)propionic acid sodium salt; 2-Fluoro-α-methyl-4-diphenylacetic acid sodium salt; Flurbiprofen sodium salt; Ocufen; Ocuflur; Sodium 3-fluoro-4-phenylhydratropate; Sodium flurbiprofen. CAS No. 56767-76-1. Pack Sizes: 5 g. Product ID: BBF-03906. Molecular formula: C15H12FNaO2. Mole weight: 266.24. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluroxypyr-[13C2] | Fluroxypyr-[13C2] is the labelled analogue of Fluroxypyr, which could be used as a herbicide as well as a synthetic auxin. Group: Pharmaceutical. Alternative Names: Fluroxypyr-13C2. Pack Sizes: 5 mg. Product ID: BLP-012364. Molecular formula: C5[13C]2H5Cl2FN2O3. Mole weight: 257.02. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone furoate | Fluticasone furoate is a synthetic corticosteroid derived from fluticasone, used for the treatment of seasonal allergic rhinitis. Uses: For treatment of seasonal allergic rhinitis. Group: Pharmaceutical. Alternative Names: Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-17-((2- furanylcarbonyl)oxy)-11-hydroxy-16-methyl-3-oxo-, S-(fluoromethyl) ester, (6alpha,11beta,16alpha,17alpha)-; Gw 685698x; Unii-js86977wnv; Veramyst; (6α,11β,16α,17α)-6,9-Difluoro-17-[(2-furanylcarbony. CAS No. 397864-44-7. Pack Sizes: 50 mg. Product ID: B0084-475694. Molecular formula: C27H29F3O6S. Mole weight: 538.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone propionate | Fluticasone propionate (Flonase, Veramyst) is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Uses: The treatment of asthma and allergic rhinitis. Group: Pharmaceutical. Alternative Names: Fluticasone Propionate, Cutivate, Flixonase, Flixotide, Flonase, Flovent; DSSTox_CID_25511; DSSTox_RID_80922; DSSTox_GSID_45511; NCGC00016943-01. CAS No. 80474-14-2. Pack Sizes: 100 mg. Product ID: NP3130. Molecular formula: C25H31F3O5S. Mole weight: 500.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity A | Fluticasone Propionate EP Impurity A is an impurity formed in the synthesis of Fluticasone propionate. Group: Pharmaceutical. Alternative Names: Fluticasone Carboxylic Acid Propionate; Fluticasone propionate-17beta-carboxylic acid; 6α,9-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17-(propanoyloxy) androsta-1,4-diene-17β-carboxylic acid; (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carboxylic Acid. CAS No. 65429-42-7. Pack Sizes: 250 mg. Product ID: B2694-074555. Molecular formula: C24H30F2O6. Mole weight: 452.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity B | Fluticasone Propionate EP Impurity B is an impurity formed in the synthesis of Fluticasone propionate. Group: Pharmaceutical. Alternative Names: Fluticasone USP Related Compound A; Fluticasone Sulfenic Acid Propionate; 6α,9-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17-(propanoyloxy)androsta-1,4-dien-17β-carbo(thioperoxoic) SO-acid. CAS No. 948566-12-9. Pack Sizes: 20 mg. Product ID: B0968-471779. Molecular formula: C24H30F2O6S. Mole weight: 484.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity C | Fluticasone Propionate EP Impurity C is an impurity of Fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Group: Pharmaceutical. Alternative Names: Fluticasone Furoate EP Impurity B; Fluticasone USP Related Compound C; Fluticasone acetate; 6α,9-Difluoro-17-[[(fluoromethyl)sulphanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl acetate. CAS No. 80474-24-4. Pack Sizes: 25 mg. Product ID: B1370-471778. Molecular formula: C24H29F3O5S. Mole weight: 486.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity D | Fluticasone Propionate EP Impurity D is an impurity of Fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Group: Pharmaceutical. Alternative Names: Fluticasone USP Related Compound D; Ticabesone propionate; Fluticasone Methylsulphanyl Analog; 6α,9-Difluoro-17-[(methylsulphanyl)carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-ylpropanoate. CAS No. 73205-13-7. Pack Sizes: 25 mg. Product ID: B1370-284468. Molecular formula: C25H32F2O5S. Mole weight: 482.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity E | Fluticasone Propionate EP Impurity E is an impurity of Fluticasone Propionate. Fluticasone Propionate is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Group: Pharmaceutical. Alternative Names: 1,2-Dihydro Fluticasone Propionate (USP); 6α,9-Difluoro-17-[[(fluoromethyl)sulphanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrost-4-en-17α-yl propanoate. CAS No. 105613-90-9. Pack Sizes: 25 mg. Product ID: B1370-257528. Molecular formula: C25H33F3O5S. Mole weight: 502.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity F | An impurity of Fluticasone, a corticosteroid used to treat symptoms of allergies like sneezing, itchy red eyes, and itchy. Group: Pharmaceutical. Alternative Names: 11-Ketofluticasone Propionate (USP); 11-Oxo Fluticasone Propionate; 6α,9-Difluoro-17-[[(fluoromethyl)sulphanyl]carbonyl]-16α-methyl-3,11-dioxoandrosta-1,4-dien-17α-yl propanoate. CAS No. 1219174-94-3. Pack Sizes: 25 mg. Product ID: B2694-471774. Molecular formula: C25H29F3O5S. Mole weight: 498.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity G | Fluticasone Propionate EP Impurity G is an impurity of Fluticasone Propionate. Fluticasone Propionate is a synthetic corticosteroid which is derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). Group: Pharmaceutical. Alternative Names: Fluticasone Furoate EP Impurity K; Fluticasone USP Related Compound E; Fluticasone Dimer Impurity; 6α,9-Difluoro-17-[[(fluoromethyl)sulphanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl 6α,9-difluoro-11β,17-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylate. CAS No. 220589-37-7. Pack Sizes: 1 mg. Product ID: B0968-471776. Molecular formula: C43H51F5O8S. Mole weight: 822.94. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate EP Impurity H | Fluticasone Propionate EP Impurity H is an impurity of fluticasone propionate, an exalted synthetic corticosteroid. Fluticasone propionate is an esteemed therapeutic agent frequently administered to treat respiratory afflictions such as asthma and allergic rhinitis. Group: Pharmaceutical. Alternative Names: Desfluoromethyl Fluticasone Propionate Disulfide; Fluticasone propionate impurity H. CAS No. 201812-64-8. Pack Sizes: 5 mg. Product ID: B1370-471782. Molecular formula: C48H58F4O10S2. Mole weight: 935.11. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone Propionate Intermediate | Fluticasone Propionate Intermediate is an impurity of fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Uses: An intermediate in the synthesis of fluticasone propionate. Group: Pharmaceutical. Alternative Names: 6,9-difluoro-11B-hydroxy-16-methyl-3-oxo-17-propionyloxyandrosta-1,4-diene-17b-carbpthioc acid; (6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxo-propoxy)androsta-1,4-diene-17-carbothioic acid. CAS No. 80474-45-9. Pack Sizes: 100 mg. Product ID: B2694-077715. Molecular formula: C24H30F2O5S. Mole weight: 468.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluticasone USP Related Compound B | Fluticasone USP Related Compound B is an impurity of Fluticasone, a man-made glucocorticoid used to treat nasal symptoms. Group: Pharmaceutical. Alternative Names: Fluticasone Trioxo Impurity; 6α,9-difluoro-11β-hydroxy-16α-methyl-3-oxo-17-(propanoyloxy) androsta-1,4-diene-17β-carboxylic acid; (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione; Fluticasone Related Compound B. CAS No. 219719-95-6. Pack Sizes: 100 mg. Product ID: B1370-176613. Molecular formula: C22H24F2O5S. Mole weight: 438.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Flutropium bromide | Flutropium bromide, a potent long-acting muscarinic antagonist, is utilized for the management of chronic obstructive pulmonary disease (COPD) to enhance pulmonary function and alleviate exacerbations. This mechanism involves the inhibition of acetylcholine's effect on muscarinic receptors within the airways, resulting in bronchodilation. Group: Pharmaceutical. CAS No. 63516-07-4. Pack Sizes: 1mg;1g;10g. Product ID: 63516-07-4. Molecular formula: C24H29BrFNO3. Mole weight: 478.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Fluxametamide | Fluxametamide, a broad-spectrum insecticide, is an antagonist of GABA- and glutamate-gated chloride channels, with IC50s of 1.95 and 225 nM for M. domestica GABACls and GluCls. Group: Pharmaceutical. Alternative Names: 4-(5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl)-N-((methoxyimino)methyl)-2-methylbenzamide; Benzamide, 4-(5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-N-((methoxyamino)methylene)-2-methyl-; 4-[5-(3,5-Dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-1,2-oxazol-3-yl]-N-[(methoxyimino)methyl]-o-toluamide. CAS No. 928783-29-3. Pack Sizes: 500 mg. Product ID: B1370-381842. Molecular formula: C20H16Cl2F3N3O3. Mole weight: 474.26. Custom synthesis is available. Send your inquiries for more information. | London |
| FMK | FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor that covalently modifies the C-terminal kinase domain of RSK. Its IC50 value is 15 nM. It could prevent the activation of the N-terminal kinase domain of RSK by the C-terminal kinase domain, but does not affect the activity of the N-terminal domain. It binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. It induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells. It is used to determine the role of RSK as a direct regulator of NHE1 phosphorylation and sarcolemmal NHE activity in this cell type, in response to 1-adrenergic stimulation. Uses: Fmk could prevent the activation of the n-terminal kinase domain of rsk by the c-terminal kinase domain, but does not affect the activity of the n-terminal domain. it is used to determine the role of rsk as a direct regulator of nhe1 phosphorylation and sarcolemmal nhe activity in this cell type, in response to 1-adrenergic stimulation. Group: Pharmaceutical. Alternative Names: 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone;RSK2 kinase inhibitor. CAS No. 821794-92-7. Pack Sizes: 10 mg. Product ID: B0084-455721. Molecular formula: C18H19FN4O2. Mole weight: 342.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-2,6-dimethyl-L-tyrosine | Fmoc-2,6-dimethyl-L-tyrosine, a derivative of tyrosine, is extensively utilized in peptide composite processes. In a myriad of studies, the peptide is known to be an effective building block in the assembly of bioactive peptides or proteins. Its application has been discovered in the realm of therapeutics too, working as a primary ingredient in drugs aiming to cure serious diseases such as cancer and neurological disorders. Group: Pharmaceutical. Alternative Names: N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-L-tyrosine; Fmoc-L-(2,6-di-Me)Tyr-OH; (S)-N-Fmoc-2,6-Dimethyltyrosine; L-Tyrosine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid. CAS No. 206060-54-0. Pack Sizes: 250 mg. Product ID: BAT-006161. Molecular formula: C26H25NO5. Mole weight: 431.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-3-(3'-Quinolyl)-L-Alanine | Fmoc-3-(3'-Quinolyl)-L-Alanine. Group: Pharmaceutical. Alternative Names: Fmoc-Ala(3'-Quinolyl)-OH; Fmoc-L-Ala[3-(3-Quinolyl)]; (S)-alpha-(Fmoc-amino)-3-Quinolinepropanoic acid. CAS No. 281655-61-6. Pack Sizes: 1 g. Product ID: BAT-014248. Molecular formula: C27H22N2O4. Mole weight: 438.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-3,4-dehydro-L-proline | Fmoc-3,4-dehydro-L-proline, a chemical intermediary employed in the synthesis of peptides within the biomedical sector, displays considerable promise with regard to the treatment of conditions such as cancer and Alzheimer's disease. Its potential medical applications are extensive and merit further exploration. Group: Pharmaceutical. Alternative Names: Fmoc-3,4-dehydro-L-Pro-OH; (S)-Fmoc-3,4-dehydro-pyrrolidine-2-carboxylic acid. CAS No. 135837-63-7. Pack Sizes: 1 g. Product ID: BAT-007331. Molecular formula: C20H17NO4. Mole weight: 335.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-4-Borono-L-Phenylalanine | Fmoc-4-Borono-L-Phenylalanine, a derivative of amino acid utilized for peptide synthesis and asymmetric synthesis catalysis, has garnered significant interest due to its promising therapeutic effects on cancer and diabetes. Numerous studies have been conducted on this compound to explore its potential for treating these diseases. Group: Pharmaceutical. Alternative Names: 4-(Dihydroxyboryl)-N-[(9H-fluoren-9-ylmethoxy)(hydroxy)methylene]-L-phenylalanine. CAS No. 273221-71-9. Pack Sizes: 100 mg. Product ID: BAT-008403. Molecular formula: C24H22BNO6. Mole weight: 431.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Arg(Pbf)-OH | Fmoc-Arg(Pbf)-OH is an amino acid derivative used in peptide synthesis. Group: Pharmaceutical. Alternative Names: Fmoc-L-Arg(Pbf)-OH; Nα-Fmoc-Nω-(2,2,4,6,7-pentamethyldihydro-benzofuran-5-sulfonyl)-L-arginine; N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine. CAS No. 154445-77-9. Pack Sizes: 250 g. Product ID: BAT-003708. Molecular formula: C34H40N4O7S. Mole weight: 648.77. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-β-Ala-Lys(Boc)-OH | Fmoc-β-Ala-Lys(Boc)-OH. Group: Pharmaceutical. Alternative Names: (2S)-6-{[(tert-butoxy)carbonyl]amino}-2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]hexanoic acid; N2-(Fmoc-beta-alanyl)-N6-Boc-L-lysine. CAS No. 1998700-95-0. Pack Sizes: 50 mg. Product ID: BAT-002442. Molecular formula: C29H37N3O7. Mole weight: 539.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. Alternative Names: Fmoc-dehydro-Ala-OH; N-(9H-Fluorene-9-ylmethoxycarbonyl)-2,3-didehydro-L-alanine; 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)acrylic acid. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: C18H15NO4. Mole weight: 309.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-D-Lys(Dde)-OH | Fmoc-D-Lys(Dde)-OH, a vital reagent for peptide synthesis, restricts the D-Lysine residue for selective introduction of D-amino acids into the peptide chains. Moreover, the Dde protection group enables mild deprotection under specific conditions during solid-phase synthesis, thus augmenting its applicability. This characteristic formulation, thus, serves as a fundamental component in the preparation of specialized peptides. Group: Pharmaceutical. Alternative Names: Nα-Fmoc-Nε-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-lysine; N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-lysine; N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)-D-lysine; N6-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine. CAS No. 333973-51-6. Pack Sizes: 5 g. Product ID: BAT-003698. Molecular formula: C31H36N2O6. Mole weight: 532.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-(Dmb)Gly-OH | Fmoc-(Dmb)Gly-OH. Group: Pharmaceutical. Alternative Names: Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH. CAS No. 166881-42-1. Pack Sizes: 10 g. Product ID: BAT-008867. Molecular formula: C26H25NO6. Mole weight: 447.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-GGFG-OH | Fmoc-GGFG-OH is a protease cleavable linker used for the antibody-drug conjugate (ADC). Group: Pharmaceutical. Alternative Names: Fmoc-Gly-Gly-Phe-Gly-OH; (((9H-Fluoren-9-yl)methoxy)carbonyl)glycylglycyl-L-phenylalanylglycine. CAS No. 1817857-75-2. Pack Sizes: 500 mg. Product ID: BADC-01446. Molecular formula: C30H30N4O7. Mole weight: 558.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-glycine | N-Fmoc-glycine is an N-Fmoc-protected form of Glycine. Glycine is a non-essential amino acid that acts as an inhibitory neyrotransmitter in the vertebrate central nervous system. Glycine also posesses cytoprotective effect against oxidant damage in the kidney. Group: Pharmaceutical. Alternative Names: Fmoc-Gly-OH; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycine; (((9H-Fluoren-9-yl)methoxy)carbonyl)glycine. CAS No. 29022-11-5. Pack Sizes: 1 kg. Product ID: BAT-003726. Molecular formula: C17H15NO4. Mole weight: 297.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Gly-Gly-Phe-OH | Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. Alternative Names: (((9H-Fluoren-9-yl)methoxy)carbonyl)glycylglycyl-L-phenylalanine; (S)-11-Benzyl-1-(9H-fluoren-9-yl)-3,6,9-trioxo-2-oxa-4,7,10-triazadodecan-12-oic acid. CAS No. 160036-44-2. Pack Sizes: 500 mg. Product ID: BADC-00972. Molecular formula: C28H27N3O6. Mole weight: 501.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-His-Aib-OH TFA | An intermediate in the synthesis of Semaglutide, an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 1446013-08-6. Pack Sizes: 100 mg. Product ID: BAT-016676. Molecular formula: C25H26N4O5.C2HF3O2. Mole weight: 576.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Leu-OH | Fmoc-Leu-OH is an amino acid derivative. It is also one of the novel PPARγ ligands that can reduce osteoclasts differentiation through activating PPARγ. Group: Pharmaceutical. Alternative Names: Fmoc-L-Leu-OH; N-(9-fluorenylmethoxycarbonyl)-L-leucine; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine; NPC 15199; NPC15199; NPC-15199. CAS No. 35661-60-0. Pack Sizes: 1 kg. Product ID: BAT-008101. Molecular formula: C21H23NO4. Mole weight: 353.42. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH is a yellowish medical intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual GIP and GLP-1 receptor agonist and a drug candidate for the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH. CAS No. 2460751-66-8. Pack Sizes: 1 g. Product ID: BAT-016679. Molecular formula: C66H105N5O16. Mole weight: 1224.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-L-Lys(Mca)-OH | Fmoc-L-Lys(Mca)-OH. Group: Pharmaceutical. Alternative Names: N-α-(9-Fluorenylmethoxycarbonyl)-N-ε-[(7-methoxycoumarin-4-yl)acetyl]-L-lysine; (S)-2-(N-(((9H-fluoren-9-yl)methyl9H-fluoren-9-yl)methoxy)carbonyl)acetamido)-6-(7-methoxy-2-oxo-2H-chromen-4-ylamino)hexanoic acid; Nα-Fmoc-Nε-7-methoxycoumarin-4-acetyl-L-lysine; Fmoc-L-Lys(Mca)-OH. CAS No. 386213-32-7. Pack Sizes: 1 g. Product ID: BAT-005458. Molecular formula: C33H32N2O8. Mole weight: 584.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH | Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH is an intermediate in the synthesis of Semaglutide. Semaglutide is a glucagon-like peptide-1 (GLP-1) analog with significant hypoglycemic efficacy. Group: Pharmaceutical. Alternative Names: Semaglutide Side Chain; (3S,30S)-3-Carboxy-30-[(1,1-dimethylethoxy)carbonyl]-9,18,27,32-tetraoxo-49-(1,1-dimethylethyl) 1-(9H-fluoren-9-ylmethyl)-11,14,20,23-tetraoxa-2,8,17,26,31-pentaazanonatetracontanedioic acid ester; (23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid. CAS No. 1662688-20-1. Pack Sizes: 1mg;1g;10g. Product ID: BAT-016675. Molecular formula: C64H101N5O16. Mole weight: 1196.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG12-propionic acid | Fmoc-N-amido-PEG12-propionic acid is a PEG linker containing a protected amino group and a carboxylic acid. The carboxylic acid can be reacted with amino groups in the presence of activators. Group: Pharmaceutical. Alternative Names: Fmoc-N-amido-PEG12-acid; Fmoc-NH-PEG12-CH2CH2COOH; Fmoc-PEG12-propionic acid; (Fmoc-amino)-PEG12-C2-Carboxylic Acid; 1-(9H-fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxa-4-azatritetracontan-43-oic acid; O-(N-Fmoc-2-aminoethyl)-O'-(2-carboxyethyl)-undecathyleneglycol; 5,8,11,14,17,20,23,26,29,32,35,38-Dodecaoxa-2-azahentetracontanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester; 1-(9H-Fluoren-9-ylmethyl)-5,8,11,14,17,20,23,26,29,32,35,38-dodecaoxa-2-azahentetracontanedioate. CAS No. 1952360-91-6. Pack Sizes: 100 mg. Product ID: B2699-278820. Molecular formula: C42H65NO16. Mole weight: 839.96. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG2-acetic acid | Fmoc-AEEA-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. Alternative Names: Fmoc-NH-PEG2-CH2COOH; Fmoc-8-amino-3,6-dioxaoctanoic acid; [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid; FMOC-AEEA; 12- (9H- Fluoren- 9- yl) - 10- oxo-3, 6, 11- trioxa- 9- azadodecanoic Acid; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic Acid; 8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic Acid; 9-Fluorenylmethoxycarbonyl-8-amino-3,6-dioxaoctanoic Acid; 2,7,10-Trioxa-4-azadodecan-12-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-. CAS No. 166108-71-0. Pack Sizes: 10 g. Product ID: BAT-007778. Molecular formula: C21H23NO6. Mole weight: 385.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-amido-PEG4-propionic acid | Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. Alternative Names: 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid; Fmoc-N-amido-PEG4-acid; Fmoc-NH-PEG4-CH2CH2COOH; Fmoc-15-Amino-4,7,10,13-tetraoxapentadecacanoic acid; 2,7,10,13,16-Pentaoxa-4-azanonadecan-19-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-; 15-(9-Fluorenylmethyloxycarbonyl)amino-4,7,10,13-tetraoxa-pentadecanoic acid; 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester; 15-(Fmoc-amino)-4,7,10,13-tetraoxapentadecanoic Acid. CAS No. 557756-85-1. Pack Sizes: 5 g. Product ID: BADC-01135. Molecular formula: C26H33NO8. Mole weight: 487.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-3-(4-py)-L-Ala | Fmoc-N-Me-3-(4-py)-L-Ala, a synthetic molecule, finds widespread use in the synthesis of peptides and proteins. Owing to its crucial role as a fundamental building block in solid-phase peptide synthesis, it has emerged as a potent weapon in the battle against numerous human maladies such as cancer and infectious diseases. With versatile functionality and chemical reactivity, the compound facilitates modifications and attachment to the peptide chain, rendering it a prized asset in the biomedical industry and a tool much sought after by researchers. Group: Pharmaceutical. Alternative Names: Fmoc-N(Me)4Pal-OH; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(pyridin-4-yl)propanoic acid. CAS No. 2381854-90-4. Pack Sizes: 1 g. Product ID: BAT-009000. Molecular formula: C24H22N2O4. Mole weight: 402.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-Asn(Trt)-OH | Fmoc-N-Me-Asn(Trt)-OH is an asparagine derivative. Group: Pharmaceutical. Alternative Names: N-α-(9-Fluorenylmethoxycarbonyl)-N-α-methyl-N-β-trityl-L-asparagine; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid. CAS No. 941296-80-6. Pack Sizes: 5 g. Product ID: BAT-004756. Molecular formula: C39H34N2O5. Mole weight: 610.72. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-Dab(Boc)-OH | Fmoc-N-Me-Dab(Boc)-OH, a peptide derivative, finds extensive applications in the pharmaceutical and biologically active compound synthesis arena. One can leverage it as a fundamental building block to engineer peptide-based drugs with proven anti-tumor activity. The versatility of Fmoc-N-Me-Dab(Boc)-OH renders it an indispensable tool in the scientific community, and its intricate molecular structure continues to inspire novel applications in the field of drug discovery and development. Group: Pharmaceutical. Alternative Names: (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid. CAS No. 2044702-38-5. Pack Sizes: 100 mg. Product ID: BAT-008506. Molecular formula: C25H30N2O6. Mole weight: 454.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-N-Me-D-Lys(Boc)-OH | Fmoc-N-Me-D-Lys(Boc)-OH is a multifaceted chemical agent that is employed in the synthetic production of proteins and peptides. This chemical is highly valued in the medical industry for its efficacy in treating infectious diseases and cancers. Scientists have also harnessed its potential for biochemical research pertaining to the design of pharmaceuticals directed towards targeted proteins. Group: Pharmaceutical. Alternative Names: Fmoc-D-N(Me)Lys(Boc)-OH. CAS No. 1793105-27-7. Pack Sizes: 5 g. Product ID: BAT-008511. Molecular formula: C27H34N2O6. Mole weight: 482.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-O-tert-butyl-L-tyrosine | Fmoc-O-tert-butyl-L-tyrosine is an amino acid protection monomer used in peptide synthesis. Group: Pharmaceutical. Alternative Names: Fmoc-L-Tyr(tBu)-OH; Fmoc-Tyr(tBu)-OH; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid; N-Fmoc-O-tert-butyl-L-tyrosine; Nalpha-Fmoc-O-tert-butyl-L-tyrosine. CAS No. 71989-38-3. Pack Sizes: 250 g. Product ID: BAT-003817. Molecular formula: C28H29NO5. Mole weight: 459.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Oxy-2-amino-2-oxoacetimidoyl cyanide | Fmoc-Oxy-2-amino-2-oxoacetimidoyl cyanide. Group: Pharmaceutical. Alternative Names: Fmoc-Amox. CAS No. 1370440-28-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008739. Molecular formula: C18H13N3O4. Mole weight: 335.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Pal-Linker | It is a reagent for the mild solid-phase synthesis of C-terminal peptide amides. Group: Pharmaceutical. Alternative Names: Pal Linker; Fmoc-Pal-Linker; 5-(4-(9-Fluorenylmethyloxycarbonyl)Aminomethyl-3,5-Dimethoxyphenoxy)Valeric Acid; 5-[3,5-Dimethoxy-4-(Fmoc-Aminomethyl)Phenoxy]Pentanoic Acid; 5-(4-(((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)Methyl)-3,5-Dimethoxyphenoxy)Pentanoic Acid. CAS No. 115109-65-4. Pack Sizes: 5 g. Product ID: BAT-004733. Molecular formula: C29H31NO7. Mole weight: 505.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Phe-Gly-OH | Fmoc-Phe-Gly-OH. Group: Pharmaceutical. Alternative Names: Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-; Fmoc-Phenylalanyl-glycine. CAS No. 169624-67-3. Pack Sizes: 5 g. Product ID: BAT-004996. Molecular formula: C26H24N2O5. Mole weight: 444.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-A(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Uses: Fmoc-pna-a(bhoc)-oh is an fmoc pna monomer containing an fmoc (9-fluorenylmethoxycarbonyl) group for solid phase peptide synthesis and a bhoc (benzhydryloxycarbonyl) protecting group for specific applications. 1. solid phase peptide synthesis (spps): the solid phase synthesis of pna oligomers is one of the primary uses of fmoc-pna-a(bhoc)-oh. stepwise assembly of pna sequences on a solid support. Group: Pharmaceutical. Alternative Names: 2-[[2-[6-[[(diphenylmethyl)oxy-oxomethyl]amino]-9-purinyl]-1-oxoethyl]-[2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]ethyl]amino]acetic acid; 2-[[2-[6-(benzhydryloxycarbonylamino)purin-9-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid. CAS No. 186046-82-2. Pack Sizes: 1 g. Product ID: BAT-008536. Molecular formula: C40H35N7O7. Mole weight: 725.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-C(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. Alternative Names: 2-[[2-[4-[[(diphenylmethyl)oxy-oxomethyl]amino]-2-oxo-1-pyrimidinyl]-1-oxoethyl]-[2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]ethyl]amino]acetic acid; 2-[[2-[4-(benzhydryloxycarbonylamino)-2-oxopyrimidin-1-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid. CAS No. 186046-81-1. Pack Sizes: 1 g. Product ID: BAT-008537. Molecular formula: C39H35N5O8. Mole weight: 701.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-G(Bhoc)-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. Alternative Names: 2-[N-[2-(Fmoc-amino)ethyl]-2-[2-[[(benzhydryloxy)carbonyl]amino]-6-oxo-1H-purin-9(6H)-yl]acetamido]acetic Acid. CAS No. 186046-83-3. Pack Sizes: 1 g. Product ID: BAT-014015. Molecular formula: C40H35N7O8. Mole weight: 741.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-thioU(PMB)-OH | Fmoc-PNA-thioU(PMB)-OH. Group: Pharmaceutical. Alternative Names: N-(2-Fmoc-aminoethyl)-N-[2-[2-(4-methoxybenzylthio)-4-oxopyrimidin-1(1H)-yl]acetyl]glycine; Glycine, N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-N-[2-[2-[[(4-methoxyphenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]acetyl]-. CAS No. 2245800-85-3. Pack Sizes: 250 mg. Product ID: BAT-017107. Molecular formula: C33H32N4O7S. Mole weight: 628.69. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-PNA-T-OH | A Fmoc PNA monomer that is a building block for the synthesis of PNA oligomers. Group: Pharmaceutical. Alternative Names: Fmoc PNA T OH. CAS No. 169396-92-3. Pack Sizes: 1 g. Product ID: BAT-008538. Molecular formula: C26H26N4O7. Mole weight: 506.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid | Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: N-β-(9-Fluorenylmethoxycarbonyl)-2,4,5-trifluoro-D-β-homophenylalanine; (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid. CAS No. 1217818-53-5. Pack Sizes: 1mg;1g;10g. Product ID: BAT-005531. Molecular formula: C25H20F3NO4. Mole weight: 455.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-acetamidomethyl-D-penicillamine | Fmoc-S-acetamidomethyl-D-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Fmoc-D-Pen(Acm)-OH; Fmoc-S-acetamidomethyl-β,β-dimethyl-D-Cys-OH; N-(fluorenylmethoxycarbonyl)-S-acetamidomethyl-D-penicillamine; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((acetamidomethyl)thio)-3-methylbutanoic acid; 3-[(Acetamidomethyl)sulfanyl]-N-{[(9H-fluoren-9-yl)methoxy]carbonyl}-D-valine. CAS No. 201531-77-3. Pack Sizes: 1mg;1g;10g. Product ID: BAT-007487. Molecular formula: C23H26N2O5S. Mole weight: 442.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-acetamidomethyl-L-penicillamine | Fmoc-S-acetamidomethyl-L-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Fmoc-L-Pen(Acm)-OH; Fmoc-S-acetamidomethyl-β,β-dimethyl-L-Cys-OH; Fmoc-Pen(Acm)-OH; N-(fluorenylmethoxycarbonyl)-S-acetamidomethyl-L-penicillamine; (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((acetamidomethyl)thio)-3-methylbutanoic acid; Fmoc-Cys(Me2)(Acm)-OH; 3-[(Acetamidomethyl)sulfanyl]-N-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-valine. CAS No. 201531-76-2. Pack Sizes: 1mg;1g;10g. Product ID: BAT-007488. Molecular formula: C23H26N2O5S. Mole weight: 442.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-benzyl-D-penicillamine | Fmoc-S-benzyl-D-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Fmoc-D-Pen(Bzl)-OH; Fmoc-S-benzyl-β,β-dimethyl-D-Cys-OH; Fmoc-D-Pen(Bn)-OH; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzylthio)-3-methylbutanoic acid; 3-(Benzylsulfanyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-valine; N-α-(9-Fluorenylmethoxycarbonyl)-S-benzyl-D-penicillamine. CAS No. 139551-73-8. Pack Sizes: 1mg;1g;10g. Product ID: BAT-007489. Molecular formula: C27H27NO4S. Mole weight: 461.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Ser(tBu)-Ser(tBu)-OH | Fmoc-Ser(tBu)-Ser(tBu)-OH is a protected dipeptide used in peptide synthesis. It features an Fmoc (Fluorenylmethyloxycarbonyl) group at the N-terminus, which protects the amino group during synthesis. Each Ser (Serine) residue is protected by a tBu (tert-butyl) group at the hydroxyl side chain, preventing unwanted side reactions. The -OH at the C-terminus indicates a free carboxyl group, allowing the dipeptide to be coupled with other amino acids. This compound is used to incorporate serine residues into peptides while maintaining the integrity of the hydroxyl groups for selective deprotection later in the synthesis process. Group: Pharmaceutical. Alternative Names: N-(Fluorenylmethoxycarbonyl)-O-tert-butyl-L-seryl-O-tert-butyl-L-serine; (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)propanamido)-3-(tert-butoxy)propanoic acid; L-Serine, O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-seryl-O-(1,1-dimethylethyl)-; L-Serine, O-(1,1-dimethylethyl)-N-[O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-seryl]-; N-(N-. CAS No. 110098-50-5. Pack Sizes: 100 mg. Product ID: BAT-002488. Molecular formula: C29H38N2O7. Mole weight: 526.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-trityl-D-penicillamine | Fmoc-S-trityl-D-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Fmoc-D-Pen(Trt)-OH; Fmoc-S-trityl-β,β-dimethyl-D-Cys-OH; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoic acid; N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-trityl-D-penicillamine; N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-3-[(triphenylmethyl)sulfanyl]-D-valine. CAS No. 201532-01-6. Pack Sizes: 1mg;1g;10g. Product ID: BAT-007490. Molecular formula: C39H35NO4S. Mole weight: 613.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-S-trityl-L-penicillamine | Fmoc-S-trityl-L-penicillamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Fmoc-L-Pen(Trt)-OH; Fmoc-S-trityl-β,β-dimethyl-L-Cys-OH; Fmoc-Pen(Trt)-OH; (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoic acid; N-Fmoc-3-(trityl-thio)-L-valine; N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-3-[(triphenylmethyl)sulfanyl]-L-valine; N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-trityl-L-penicillamine. CAS No. 201531-88-6. Pack Sizes: 5 g. Product ID: BAT-007492. Molecular formula: C39H35NO4S. Mole weight: 613.77. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Thr[GalNAc(Ac)3-α-D]-OH | Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a biomedical compound used for the research of diseases involving abnormal glycosylation processes. It functions as a glycosylation inhibitor, targeting enzymes responsible for glycan modification. This product aids in the study and understanding of glycosylation-related disorders. Group: Pharmaceutical. Alternative Names: Fmoc-Thr(Ac3AcNH-α-Gal)-OH; Fmoc-L-Thr(TnAc4)-OH; N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine; Fmoc-Thr[GalNAc(Ac)3-alpha-D]-OH. CAS No. 116783-35-8. Pack Sizes: 25 mg. Product ID: BAT-008014. Molecular formula: C33H38N2O13. Mole weight: 670.66. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-trans-4-methyl-L-Pro-OH | Fmoc-trans-4-methyl-L-Pro-OH. Group: Pharmaceutical. Alternative Names: N-(9-Fluorenylmethoxycarbonyl)-(2S,4R)-4-methylproline; 1-(9H-Fluorene-9-ylmethoxycarbonyl)-4beta-methyl-L-proline; Fmoc-trans-4-Amc-OH; Fmoc-trans-4-methyl-L-proline; (2S,4R)-Fmoc-4-Methyl-L-Pro-OH; (4R)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-proline; 1,2-Pyrrolidinedicarboxylic acid, 4-methyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,4R)-. CAS No. 333777-34-7. Pack Sizes: 50 mg. Product ID: BAT-010883. Molecular formula: C21H21NO4. Mole weight: 351.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Val-Ala-OH | Fmoc-Val-Ala-OH is a widely used cleavable peptide linker that can conveniently serve as a building block for the careful construction of peptide-directed therapeutics and pharmaceuticals. Its multifaceted nature holds great promise in combating a range of diseases, including but not limited to neoplastic diseases, autoimmune diseases, and potential infections. Group: Pharmaceutical. Alternative Names: (S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)propanoic acid; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-L-alanine. CAS No. 150114-97-9. Pack Sizes: 500 mg. Product ID: BAT-002431. Molecular formula: C23H26N2O5. Mole weight: 410.46. Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.